Pharma BD Deal Intelligence
Pfizer Inc. / Protalix BioTherapeutics, Inc.
2009 · Licensing/Option · $175M · Complete
Announcement Sentiment
83
Strongly positive
$60M upfront + ~$115M milestones for taliglucerase alfa (ELELYSO) for Gaucher disease ex-Israel. Source: Protalix IR, Pfizer press.
Key facts
- Announced Nov 30, 2009
- Deal value $175M
- Deal type Licensing/Option
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals